SCHEMBL12799786

SCHEMBL12799786

Cc1cc(C)c2oc3ccccc3c2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 1/20 0.49
AHR P35869 3/20 0.49
CYP1A2 P05177 2/20 0.44
CYP2A6 P11509 1/20 0.44
MAOA P21397 2/20 0.44
CSNK2A2 P19784 2/20 0.42
CSNK2B P67870 2/20 0.42
CSNK2A1 P68400 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
LMNA P02545 1/20 0.42
MAOB P27338 2/20 0.40
KDM4E B2RXH2 2/20 0.40
MEN1 O00255 2/20 0.40
ALDH1A1 P00352 2/20 0.40
KMT2A Q03164 2/20 0.40
TNKS O95271 1/20 0.40
PARP1 P09874 1/20 0.40
TNKS2 Q9H2K2 1/20 0.40
PARP2 Q9UGN5 1/20 0.40
NPC1 O15118 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29838129 0.86 TTR (0.67) TTRMAOASMN1; SMN2LMNAKDM4E
SCHEMBL131997 0.86 TTR (0.44) TTRAHRCYP1A2CYP2A6MAOA
SCHEMBL7253352 0.86 TTR (0.67) TTRMAOASMN1; SMN2LMNAKDM4E
Xanthone SCHEMBL10615991 0.84 TTR (0.65) TTRMAOASMN1; SMN2LMNAKDM4E
SCHEMBL12799743 0.82 CSNK2A2 (0.47) CSNK2A2CSNK2BCSNK2A1SMN1; SMN2KDM4E
SCHEMBL23176963 0.81 ALDH1A1 (0.55) TTRAHRCYP1A2MAOASMN1; SMN2
SCHEMBL21912830 0.81 TTR (0.47) TTRAHRCYP1A2MAOASMN1; SMN2
SCHEMBL23340144 0.81 AHR (0.46) AHRMAOASMN1; SMN2LMNAMAOB
SCHEMBL20726239 0.81 AHR (0.46) TTRAHRMAOASMN1; SMN2MAOB
SCHEMBL22815436 0.81 AHR (0.60) TTRAHRCYP1A2MAOASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12041851-B2 Compound and organic light emitting device comprising same LG CHEM, LTD. (KR) 2024-07-16 US disclosed
US-11802123-B2 Heterocyclic compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2023-10-31 US disclosed
US-20230301182-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-09-21 US disclosed
US-20230301182-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-09-21 US disclosed
US-11744152-B2 Benzimidazo[1,2-a]benzimidazole derivatives for electronic applications UDC IRELAND LIMITED (IE) 2023-08-29 US disclosed
US-11744152-B2 Benzimidazo[1,2-a]benzimidazole derivatives for electronic applications UDC IRELAND LIMITED (IE) 2023-08-29 US disclosed
US-20230240136-A1 First and Second Organic Semiconductor Layer and Organic Electronic Device Comprising the Same NOVALED GMBH (DE) 2023-07-27 US disclosed
US-20230240136-A1 First and Second Organic Semiconductor Layer and Organic Electronic Device Comprising the Same NOVALED GMBH (DE) 2023-07-27 US disclosed
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 US disclosed
EP-4124619-A1 COMPOUND, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE COMPOUND Idemitsu Kosan Co., Ltd. (JP) 2023-02-01 EP disclosed
US-20150322337-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, ILLUMINATION DEVICE, AND DISPLAY DEVICE Konica Minolta, Inc. (JP) 2015-11-12 US disclosed
EP-2930762-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, ILLUMINATION DEVICE, AND DISPLAY DEVICE Konica Minolta, Inc. (JP) 2015-10-14 EP disclosed
US-20150243907-A1 AZADIBENZOFURANS FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2015-08-27 US disclosed
US-20150207083-A1 BENZIMIDAZO[1,2-A]BENZIMIDAZOLE DERIVATIVES FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2015-07-23 US disclosed
US-20140252280-A1 4H-IMIDAZO[1,2-A]IMIDAZOLES FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2014-09-11 US disclosed
US-20140252280-A1 4H-IMIDAZO[1,2-A]IMIDAZOLES FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2014-09-11 US disclosed
WO-2013068376-A1 4H-IMIDAZO[1,2-A]IMIDAZOLES FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2013-05-16 WO disclosed
WO-2012130709-A1 4H-IMIDAZO[1,2-A]IMIDAZOLES FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2012-10-04 WO disclosed
US-20120241681-A1 4H-Imidazo[1,2-a]imidazoles for Electronic Applications BASF SE (DE) 2012-09-27 US disclosed
US-20120241681-A1 4H-Imidazo[1,2-a]imidazoles for Electronic Applications BASF SE (DE) 2012-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120241681-A1 4H-Imidazo[1,2-a]imidazoles for Electronic Applications EIF4A1, ITPR2, ITPR1 TTR 3311/4885AHR 2907/4885CYP1A2 506/4885
US-11802123-B2 Heterocyclic compound and organic light emitting device comprising the same CRY1, CRY2, PPOX TTR 4357/4885AHR 20/4885CYP1A2 35/4885
US-20150243907-A1 AZADIBENZOFURANS FOR ELECTRONIC APPLICATIONS AZI2, BRPF1, CCNB1 TTR 2758/4885AHR 3260/4885CYP1A2 353/4885
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes KCNQ2, KCNQ1, KCNQ4 TTR 2780/4885AHR 1070/4885CYP1A2 1154/4885
US-20230301182-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME OR10J3, ESR1, EPCAM TTR 1634/4885AHR 2975/4885CYP1A2 428/4885
US-12041851-B2 Compound and organic light emitting device comprising same CRY1, CYP1A1, TRPA1 TTR 3135/4885AHR 407/4885CYP1A2 15/4885
US-11744152-B2 Benzimidazo[1,2-a]benzimidazole derivatives for electronic applications PAICS, EIF4A1, ECI1 TTR 3308/4885AHR 3738/4885CYP1A2 896/4885
US-20230240136-A1 First and Second Organic Semiconductor Layer and Organic Electronic Device Comprising the Same OR10J3, AXIN2, POU2F1 TTR 2307/4885AHR 1207/4885CYP1A2 191/4885
US-20150207083-A1 BENZIMIDAZO[1,2-A]BENZIMIDAZOLE DERIVATIVES FOR ELECTRONIC APPLICATIONS PAICS, EIF4A1, ECI1 TTR 3308/4885AHR 3738/4885CYP1A2 896/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.